Tenaya Therapeutics/$TNYA
About Tenaya Therapeutics
Ticker
Industry
Employees
TNYA Metrics
$95M
-
-$1.44
2.35
-
Price and volume
Market cap
$95M
Beta
2.35
52-week high
$7.01
52-week low
$0.86
Average daily volume
2M
Financial strength
Current ratio
5.275
Quick ratio
4.912
Long term debt to equity
10.237
Total debt to equity
12.911
Management effectiveness
Return on assets (TTM)
-45.94%
Return on equity (TTM)
-84.49%
Valuation
Price to book
0.84
Price to tangible book (TTM)
0.84
Price to free cash flow (TTM)
-1.031
Growth
Earnings per share change (TTM)
-22.33%
3-year earnings per share growth (CAGR)
-42.27%
What the Analysts think about TNYA
Analyst Ratings
TNYA Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
TNYA Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
TNYA News

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024
What’s the current market cap for Tenaya Therapeutics stock?
What is the P/E ratio for Tenaya Therapeutics stock?
Does Tenaya Therapeutics stock pay dividends?
No, Tenaya Therapeutics (TNYA) stock does not pay dividends to its shareholders as of February 18, 2025.
When is the next Tenaya Therapeutics dividend payment date?
Tenaya Therapeutics (TNYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tenaya Therapeutics?
Tenaya Therapeutics (TNYA) has a beta rating of 2.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.